A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies

NCT05028478 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Solid Tumor
Metastatic Solid Tumor
Hematologic Malignancies

Interventions

DRUG: CN202

Sponsor

Curon Biopharmaceutical (Australia) Co Pty Ltd

Collaborators

[object Object]